Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis

scientific article published on 23 July 2007

Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.00890-07
P932PMC publication ID2043270
P698PubMed publication ID17646422
P5875ResearchGate publication ID6193066

P2093author name stringBarbara Cappelli
Andrea Novelli
Elio Castagnola
Maura Faraci
Stefania Fallani
Maria Iris Cassetta
P2860cites workPharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsQ34123805
Voriconazole: a new triazole antifungal agentQ35069136
Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.Q39652915
Determination of MICs of aminocandin for Candida spp. and filamentous fungiQ41071178
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapyQ45172488
Allogeneic bone marrow transplantation for Pearson's syndromeQ79862610
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectaspergillosisQ259626
P304page(s)3775
P577publication date2007-07-23
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleMaintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis
P478volume51

Search more.